Detailed price information for Amylyx Pharmaceuticals Inc (AMLX-Q) from The Globe and Mail including charting and trades.

Mallinckrodt announced that the Irish High Court has given the necessary ruling to enable its combination with Endo, ...

Setmelanotide was associated with significant weight reduction among patients aged 4 years and older with acquired hypothalamic obesity.

The awards will be handed out at a gala event scheduled for October 9 at New York City’s Cipriani Wall Street.

JULY 2025 at 12:00 EEST Orion Group Half-Year Financial Report January-June 2025 April-June 2025 Highlights Net sales totalled EUR 416.5 (April-June ...

A webcast and a conference call for analysts, investors and media representatives will be held on Friday, 18 July 2025 at 13.30 EEST. A link to the live webcast is available on Orion's website at ...

Closing of the Merger Expected in Early August DUBLIN, July 17, 2025 /PRNewswire/ -- Mallinckrodt plc today announced that the Irish High Court has given the necessary ruling to enable ...

GLP-1 anti-obesity medications are linked with improvements in testosterone levels and health outcomes for men with obesity ...

Key TakeawaysThe weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer. Tumor ...

New Phase II data presented at ENDO 2025 highlight avexitide’s potential to significantly reduce severe hypoglycemic events ...

Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) is one of the best low priced pharma stocks to buy now. On July 13, Amylyx Pharmaceuticals announced new exploratory analyses from its Phase 2 PREVENT and ...